Acknowledgements	O

The	O
authors	O
gratefully	O
acknowledge	O
the	O
support	O
of	O
DRUID	O
study	O
participants	O
,	O
study	O
staff	O
,	O
members	O
of	O
the	O
Indigenous	O
Steering	O
Group	O
,	O
and	O
partner	O
organisations	O
.	O

The	O
DRUID	O
Study	O
was	O
funded	O
by	O
the	O
National	O
Health	O
and	O
Medical	O
Research	O
Council	O
(	O
NHMRC	O
Project	O
Grant	O
#	O
236207	O
)	O
,	O
with	O
additional	O
support	O
from	O
the	O
Australian	O
Government	O
Department	O
of	O
Employment	O
and	O
Workplace	O
Relations	O
,	O
the	O
Clive	O
and	O
Vera	O
Ramaciotti	O
Foundation	O
,	O
the	O
Vincent	O
Fairfax	O
Family	O
Foundation	O
,	O
the	O
International	O
Diabetes	O
Institute	O
(	O
AusDiab	O
Partnership	O
)	O
,	O
and	O
Bayer	O
HealthCare	O
.	O

The	O
DRUID	O
Study	O
is	O
an	O
in	O
-	O
kind	O
project	O
of	O
the	O
Cooperative	O
Research	O
Centre	O
for	O
Aboriginal	O
Health	O
.	O

LMB	O
had	O
a	O
NHMRC	O
Scholarship	O
2003	O
-	O
5	O
and	O
is	O
supported	O
by	O
NHMRC	O
Training	O
Fellowship	O
(	O
#	O
605837	O
)	O
,	O
NHMRC	O
#	O
320860	O
and	O
the	O
Centre	O
of	O
Clinical	O
Research	O
Excellence	O
in	O
Clinical	O
Science	O
in	O
Diabetes	O
,	O
University	O
of	O
Melbourne	O
.	O

JC	O
was	O
supported	O
by	O
a	O
NHMRC	O
Career	O
Development	O
Award	O
(	O
#	O
283310	O
)	O
and	O
a	O
NHMRC	O
Research	O
Fellowship	O
(	O
#	O
545200	O
)	O
.	O

AH	O
is	O
supported	O
by	O
NHMRC	O
Fellowship	O
(	O
#	O
520316	O
)	O
.	O

Thank	O
you	O
to	O
Dr	O
Jaquelyne	O
Hughes	O
for	O
comments	O
on	O
the	O
manuscript	O
.	O

Funding	O
sources	O
played	O
no	O
role	O
in	O
the	O
study	O
design	O
,	O
in	O
the	O
collection	O
,	O
analysis	O
and	O
interpretation	O
of	O
the	O
data	O
,	O
in	O
the	O
writing	O
of	O
the	O
manuscript	O
,	O
or	O
in	O
the	O
decision	O
to	O
submit	O
the	O
manuscript	O
for	O
publication	O
.	O

